Fox Run Management, L.L.C. Blueprint Medicines Corp Transaction History
Fox Run Management, L.L.C.
- $526 Million
- Q4 2024
A detailed history of Fox Run Management, L.L.C. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 10,264 shares of BPMC stock, worth $955,373. This represents 0.17% of its overall portfolio holdings.
Number of Shares
10,264
Previous 2,830
262.69%
Holding current value
$955,373
Previous $261,000
242.91%
% of portfolio
0.17%
Previous 0.06%
Shares
11 transactions
Others Institutions Holding BPMC
# of Institutions
379Shares Held
61.6MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$631 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$619 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$529 Million0.06% of portfolio
-
State Street Corp Boston, MA2.5MShares$233 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.94MShares$181 Million0.44% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.56B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...